Boston Scientific Announces Results For Second Quarter 2018
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Supermicro probe finds no senior management link to export violations
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
Boston Scientific (BSX) Tops Q2 EPS by 7c; Issues Solid Outlook
July 25, 2018 6:32 AM EDTBoston Scientific (NYSE: BSX) reported Q2 EPS of $0.41, $0.07 better than the analyst estimate of $0.34. Revenue for the quarter came in at $2.49 billion versus the consensus estimate of $2.47 billion.
GUIDANCE:
Boston Scientific sees Q3 2018 EPS of $0.33-$0.35, versus the consensus... More
